CIO Bulletin

CIO Bulletin
May 2018

Company	Management	Description
Biogen www.biogen.com	Michel Vounatsos, CEO	Biogen is a pioneer in biotechnology, and today the company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. Biogen also manufactures and commercializes biosimilars of advanced biologics.
ChromaDex www.chromadex.com	Frank L. Jaksch Jr, Co- Founder and CEO	ChromaDex Corp. is an integrated, global nutraceutical company devoted to improving the way people age. ChromaDex scientists partner with leading universities and research institutions worldwide to uncover the full potential of NAD and identify and develop novel, science-based ingredients including pTeroPure^® pterostilbene; PURENERGY^®, a caffeine-pTeroPure^® co-crystal; AnthOrigin™, anthocyanins and NIAGEN^® nicotinamide riboside - sold directly to consumers as the supplement, TRU NIAGEN^®. TRU NIAGEN^® is helping the world AGE BETTER^®.
Urobiologics LLC www.urobiologics.com	Dr. Kuldeep Verma, Founder	Urobiologics is the first company to develop and commercially introduce preconception gender planning and post-conception gender determination by testing urine. It is its mission to help couples plan & have a small balanced family for happy living. The company has a unique technology to help couples plan for a baby of specific gender and also to evaluate the gender of the baby from as early as you can do the pregnancy test. This is the earliest and most accurate test in the world, currently holding an expected accuracy rate of approximately 95%.
Titan Pharmaceuticals Inc. www.titanpharm.com	Sunil Bhonsle, President & CEO	Titan is a specialty pharmaceuticals company that develops therapeutics for select chronic diseases utilizing its innovative, long-term, continuous drug delivery platform, ProNeura. The company's lead product is Probuphine, a six-month buprenorphine implant for the maintenance treatment of opioid addiction. The U.S. Food and Drug Administration approved Probuphine on May 26, 2016. Probuphine is the first marketed product to provide maintenance treatment of opioid addiction continuously for six months following a single administration procedure.
Ceresoft www.ceresoft.com	Dr. Hsing-Hen Chen, Founder & CEO	For over 20 years, CereSoft has provided cutting edge services to its clients in the healthcare industry, while demonstrating thought leadership in technology services throughout the United States. With over 200 employees worldwide, CereSoft maintains a workforce that can handle all of the revenue cycle needs of both burgeoning and established healthcare providers and financial institutions.
Stratus Interoperable www.stratusinteroperable.com	Fred Zolla, Executive Chairman	Stratus Interoperable™ was founded by healthcare data and technology leaders committed to building an all-in-one tool that would provide the data access, analysis and distribution capabilities needed by healthcare organizations to continually improve patient outcomes, reduce costs and compete in the Value-based economy. StratusLink™, the company's revolutionary Data Management and Business Intelligence platform, puts all your data right at your fingertips—wherever and whenever you need it.
MaxMD www.maxmdirect.com	Scott A. Finlay, Founder & CEO	MaxMD is a leader in secure healthcare information technology and interoperability solutions. MaxMD is committed to providing secure communications solutions that enable superior coordinated care for healthcare practices, organizations, hospital systems and HIT application service providers. All MaxMD products are designed for effective care coordination through scalable and sustainable data sharing between disparate system and separate legal entities.
Prasco www.prasco.com	Mr. E. Thomas Arington Co-founder & CEO	Prasco is an independent, innovative healthcare company that uses a complete approach designed to expand horizons for our partners, customers, and patients. Placing a high value on its insight, dedication, and expertise, industry-leading companies rely on Prasco for solutions within the generic, Authorized Generic, and brand markets.
Rethink www.rethinkfirst.com	Mr. Etra, CEO	Rethink aims to provide families, educators and behavior healthcare providers affordable, best practice treatment solutions for children with special needs. Rethink is unique in its foot-print offering clinical support, best-practice tools, and research-based content via technology to all market segments, reaching more children with special needs than any other solution.
Crescendo Bioscience www.crescendobio.com	Bernard Tobin, President	Crescendo Bioscience concentrates its efforts in rheumatology and is currently focused on rheumatoid arthritis (RA), a debilitating, chronic disease affecting over 1.5 million people in the United States and more than 2 million in Europe. Although there is no known cure for RA, multiple therapies are available, with widely differing levels of effectiveness and significant potential toxicities. Choosing the optimal treatment from among these therapeutic alternatives is a tremendous challenge.